HHealth Read More There’s a Fatty Liver Epidemic. AI Could Help Get Ahead of ItAugust 13, 2026 All over the world, a slow, insidious change is taking place in the composition of the livers of…
HHealth Read More Immune Memory Mechanism Emerges as a Promising Target in Diabetes and Its ComplicationsAugust 12, 2026 Newswise — A growing understanding of trained immunity, a form of long-lasting immune system adaptation, is reshaping how scientists…
MMedication Read More GLP-1s not a ‘lifestyle product’ – The StarAugust 5, 2026 GLP-1s not a ‘lifestyle product’ The StarCalls to poison centers skyrocket amid rise in use of GLP-1 drugs, experts…
FFitness Read More Once-weekly workout burns nearly as much fat as 3 workouts a weekAugust 3, 2026 One and done. The CDC and other health agencies recommend adults aim for at least 150 minutes of…
HHealth Read More Daily tomatoes lowered a key marker of liver fat in MASLD trialAugust 3, 2026 A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
HHealth Read More Traditional Japanese medicine for obesity may help reduce age-related tissue fibrosisAugust 3, 2026 A traditional Japanese medicine used for obesity may do more than support weight loss. Researchers at the University…
HHealthcare Read More Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ CommentsAugust 1, 2026 The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
SScience Read More Ten-million-person study links semaglutide to lower COVID-19 mortalityJuly 31, 2026 After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
MMedication Read More Loving your body in a world where weight stigma helps sell GLP-1 drugsJuly 30, 2026 Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
HHealth Read More Northern Ireland moves to tackle obesity with new restrictions on unhealthy food promotions | Food Standards AgencyJuly 29, 2026 Obesity is one of the biggest public health challenges facing Northern Ireland, with 65% of adults living with…
HHealthcare Read More Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ CommentsJuly 28, 2026 The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
MMedication Read More TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorderJuly 28, 2026 The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…